BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25405572)

  • 1. Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study.
    Everhov ÅH; Nyberg T; Bergmark K; Citarella A; Rådestad AF; Hirschberg AL; Smedby KE
    Menopause; 2015 Jun; 22(6):633-9. PubMed ID: 25405572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy might be underutilized in women with early menopause.
    Lindh-Åstrand L; Hoffmann M; Järvstråt L; Fredriksson M; Hammar M; Spetz Holm AC
    Hum Reprod; 2015 Apr; 30(4):848-52. PubMed ID: 25662809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice patterns with hormone therapy after surgical menopause.
    Chubaty A; Shandro MT; Schuurmans N; Yuksel N
    Maturitas; 2011 May; 69(1):69-73. PubMed ID: 21396791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
    Fournier A; Fritel X; Panjo H; Zins M; Ringa V
    Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of hormone therapy (HT) among Swedish women with contraindications - A pharmacoepidemiological cohort study.
    Lindh-Åstrand L; Hoffmann M; Fredrikson M; Hammar M; Spetz Holm AC
    Maturitas; 2019 May; 123():55-60. PubMed ID: 31027678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hormone therapy in Swedish women aged 80 years or older.
    Järvstråt L; Spetz Holm AC; Lindh-Åstrand L; Hoffmann MJ; Fredrikson MG; Hammar ML
    Menopause; 2015 Mar; 22(3):275-8. PubMed ID: 25051289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms.
    Lindh-Astrand L; Bixo M; Hirschberg AL; Sundström-Poromaa I; Hammar M
    Menopause; 2010; 17(1):72-9. PubMed ID: 19675505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormones down under: hormone therapy use after the Women's Health Initiative.
    Travers C; O'Neill SM; Khoo SK; King R
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):330-5. PubMed ID: 16866795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hot flushes, hormone therapy and alternative treatments: 30 years of experience from Sweden.
    Lindh-Åstrand L; Hoffmann M; Hammar M; Spetz Holm AC
    Climacteric; 2015 Feb; 18(1):53-62. PubMed ID: 24742038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
    Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
    Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.
    Hoffmann M; Hammar M; Kjellgren KI; Lindh-Astrand L; Brynhildsen J
    Maturitas; 2005 Sep; 52(1):11-7. PubMed ID: 16023804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared decision-making on the use of hormone therapy: a nationwide survey in the Republic of Korea.
    An AR; Shin DW; Chun SH; Lee HK; Ko YJ; Lee H; Son KY; Choi HC; Cho B; Lee JK; Kim JG
    Menopause; 2014 Jul; 21(7):726-31. PubMed ID: 24378764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression and the menopause: why antidepressants are not enough?
    Graziottin A; Serafini A
    Menopause Int; 2009 Jun; 15(2):76-81. PubMed ID: 19465674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
    Barbaglia G; Macià F; Comas M; Sala M; del Mar Vernet M; Casamitjana M; Castells X
    Menopause; 2009; 16(5):1061-4. PubMed ID: 19369903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.